175
Views
2
CrossRef citations to date
0
Altmetric
Letter

Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials

, , , , , , , , , , & show all
Pages 2310-2313 | Received 09 Nov 2012, Accepted 28 Jan 2013, Published online: 28 Feb 2013
 

Acknowledgements

In particular, we thank Gabriela Vankova, Alexandra Oltova, Jana Brezinova and Kyra Michalova for cytogenetic analyses and data-managers Blanka Dobesova and Jana Rysava for data collection. We also thank Rich Zimmerman for his English text review and corrections.

Potential conflict of interest:

This work was supported by CELL – The CzEch Leukemia Study Group for Life. Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.